
Google has been accused of profiting from false hope after running adverts for unproven dementia treatments which can cost as …

The first day of June – time for another top ten run-down. It’s been a week somewhat characterised by trial …

Health and drug development-focused artificial intelligence firm BenevolentAI has announced that former UK Minister for Internet Security and Safety Joanna …

Google and Verily Life Sciences, a subsidiary within Alphabet, focused on developing health-tech, have revealed the fruits of a combined …

Jeff Huber, a former Google executive who spent 14 years at the company, has announced that he will step from …

Releasing 20 million mosquitoes does not sound like the right way to go about reducing the overall population; however, the …

DeepMind’s deal with the NHS to develop an app that is able to detect possible kidney damage involved 1.6 million …

Verily, a life sciences company owned by Alphabet, Google’s umbrella company, has announced that it has received $800 million in …

As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
As part of the news that French drugmaker Sanofi and Google parent Alphabet’s life sciences firm Verily are to join …

Sanofi is set to join forces with Alphabet’s life sciences firm Verily in a $500 million partnership to develop diabetes …

It’s Friday, and we’ve seen some big developments in the industry’s headlines throughout the week, from news of Glaxo-Smith-Kilne’s new …

GlaxoSmithKline and Verily Life Sciences, a division of Google’s parent company Alphabet, have announced a £540 million partnership that will …

Google’s artificial intelligence company DeepMind Technologies wants to apply its machine learning technology to NHS patient data within the next …

Alphabet Inc (Nasdaq: GOOG) has filed a patent application for a device that can be implanted in the eye to …